{
    "organizations": [],
    "uuid": "d86918b09038ec833e4dd7850d91d44acdb53547",
    "author": "",
    "url": "https://www.reuters.com/article/brief-supernus-announces-pricing-of-350/brief-supernus-announces-pricing-of-350-mln-private-offering-of-0-625-pct-convertible-senior-notes-idUSASC09SDL",
    "ord_in_thread": 0,
    "title": "BRIEF-Supernus Announces Pricing Of $350 Mln Private Offering Of 0.625 Pct Convertible Senior Notes",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 26 AM / Updated 14 minutes ago BRIEF-Supernus Announces Pricing Of $350 Mln Private Offering Of 0.625 Pct Convertible Senior Notes Reuters Staff March 15 (Reuters) - Supernus Pharmaceuticals Inc: * SUPERNUS ANNOUNCES PRICING OF $350 MILLION PRIVATE OFFERING OF 0.625% CONVERTIBLE SENIOR NOTES * SUPERNUS PHARMACEUTICALS INC - ‍PRICING OF PRIVATE OFFERING OF $350 MILLION 0.625% CONVERTIBLE SENIOR NOTES DUE 2023​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-15T13:24:00.000+02:00",
    "crawled": "2018-03-15T13:49:28.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "announces",
        "pricing",
        "mln",
        "private",
        "offering",
        "pct",
        "convertible",
        "senior",
        "note",
        "reuters",
        "staff",
        "march",
        "reuters",
        "supernus",
        "pharmaceutical",
        "inc",
        "supernus",
        "announces",
        "pricing",
        "million",
        "private",
        "offering",
        "convertible",
        "senior",
        "note",
        "supernus",
        "pharmaceutical",
        "inc",
        "private",
        "offering",
        "million",
        "convertible",
        "senior",
        "note",
        "due",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}